FDA authorizes COVID-19 oral antiviral developed at Emory
The U.S. Food and Drug Administration (FDA) authorized molnupiravir, an antiviral pill, for...
Read MoreThe U.S. Food and Drug Administration (FDA) authorized molnupiravir, an antiviral pill, for...
Read MoreThe Food and Drug Administration (FDA) advisory board voted to recommend that the government...
Read MoreThe School of Medicine began to enroll participants in Novavax, Inc.’s Phase 3 trial of a...
Read MoreOn Oct. 5, President Donald Trump returned to the White House after a three-day hospitalization at Walter Reed National Military Medical Center. Seemingly unbothered by his recent COVID-19 diagnosis, he quickly removed his mask...
Read MoreEmory doctors are collecting and transfusing plasma from virus survivors to infected patients as...
Read More